Spironolactone And Hydrochlorothiazide Tablet
Product Images NDC 0378-0403

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Spironolactone And Hydrochlorothiazide (NDC 0378-0403). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image 01

Chemical structure diagram of spironolactone, one of the active ingredients in Spironolactone and Hydrochlorothiazide oral tablets by Mylan Pharmaceuticals Inc.*

FDA Label Image

Image 02

Chemical structure diagram of spironolactone and hydrochlorothiazide active ingredients, showing a chlorinated benzene ring with sulfonamide and other functional groups bonded to it.*

FDA Label Image

Image 03

Packaging label for Spironolactone and Hydrochlorothiazide 25 mg/25 mg oral tablets by Mylan Pharmaceuticals Inc. The label shows the NDC 0378-0403-01 and indicates a bottle containing 100 tablets. It includes a yellow round tablet imprint M 41 and storage instructions for controlled room temperature.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.